Around the globe, medicines regulators approve new drugs after reviewing data from clinical trials. It is these trial data that underlie assuring determinations, like those made by the US Food […]
An examination of compulsive hoarding in light of upgrading it to its own classification in the newest DSM release.
Calls for a Homeland Security approach to mental illness provides for the creation of an “at risk” population that is not only treatable but incurable…and highly profitable.
The family physician, a dying breed, already replaced by better paid second- and third-line technical specialists then proactive laboratory-based preventive measures based on schedules to screen for anomalies in plasma molecules, in body images and soon in genetic material that treat the “molecules” rather than the patient — all to address risks that are almost certainly exaggerated.
Inadequate sleep is called an epidemic with serious implications for health and productivity. Pharmaceutical solutions are growing, but are they the answer — or even necessary?
There needs to be more transparency in clinical drug trials including the value of the drugs from the viewpoint of patient benefit, reasons for terminating early, outsourcing to developing countries and a focus on efficacy rather than economics.
Seniors are increasingly being over-medicated and experiencing a “prescribing cascade” where drug symptoms are treated with additional medications. This leads to increased healthcare costs and a declining quality of life for our seniors.